Fundz

Biotia raises $9M in funding to enhance diagnostics in women's health and expand into orthopedic diagnostics.

PRIVATEOct 01, 2026

Amount Raised

$9 Million

Round Type

Venture

New YorkBiotechnologyHealth CareArtificial IntelligenceHealth Diagnostics

Investors

Red Bear VenturesDr. Clive FieldsTim BarryCloquet Capital PartnersContinuum Health VenturesI Lab AngelsEgb CapitalLeawood Venture CapitalRed Bear AngelsConvergent VenturesDigitalDx Ventures

Description

Biotia, based in NYC, raised $9M in financing from multiple backers including Convergent Ventures and DigitalDx Ventures. The funds will be used to launch additional diagnostics and pursue reimbursement efforts. Biotia focuses on infectious disease diagnostics using AI and clinical metagenomics. They operate a CLIA-certified laboratory in NYC, offering testing across all 50 U.S

Quick answer

Biotia raised $9 Million in a funding round, dated October 1, 2026. Investors: Red Bear Ventures, Dr. Clive Fields, Tim Barry, Cloquet Capital Partners, Continuum Health Ventures, I Lab Angels, Egb Capital and Leawood Venture Capital. Biotia is based in New York, United States.

How much did Biotia raise?
Biotia raised $9 Million in a funding round on October 1, 2026.
Who invested in Biotia?
Red Bear Ventures, Dr. Clive Fields, Tim Barry, Cloquet Capital Partners, Continuum Health Ventures, I Lab Angels, Egb Capital and Leawood Venture Capital are named as investors in this round.
What does Biotia do?
Biotia is a health tech company located in New York, NY, that leverages sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance.
Where is Biotia based and how big is it?
Biotia is based in New York, United States. Fundz records about 28 employees.
Who are the decision-makers at Biotia?
Fundz holds 1 contact at Biotia, including the CEO and Co-founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Health Diagnostics and Biotechnology around the same time

Companies in the same sectors as Biotia that raised within 45 days of this round, from Fundz verified event records.

  • Alterra Labs raised $13M (Seed) on November 10, 2026.
  • Laza Medical raised $160M (Series B) on November 4, 2026.
  • Pathos AI raised $237M (Series E) on October 23, 2026.
  • BioStack raised $9.5M (Seed) on October 22, 2026.
  • Coherence Neuro raised $45M (Series A) on October 22, 2026.
  • Wavena raised $150K (Seed) on October 8, 2026.

Who to call at Biotia, and when

A new round usually means Biotia is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Biotia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Biotia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Biotia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Biotia

Location

New York, United States

About

Biotia is a health tech company located in New York, NY, that leverages sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance. Their mission is to fight infectious diseases by deploying the leading reference library of microbes worldwide. Biotia, a spinout company of Jacobs Technion-Cornell Institute at Cornell Tech, has a New York State CLIA lab for infectious disease diagnostics testing affiliated with SUNY Downstate Health Sciences University. Connect on Twitter | Facebook | LinkedIn

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Biotia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNiamh O., CEO and Co-founder hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Biotia's next move

See what Strategic adds

Biotia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.